BioByte 121: biology as the next software platform, language development in children, a massive Perturb-seq dataset, and morning coffee as a cancer treatment

BioByte 120: FutureHouse launches ether0, introducing Origene as a virtual disease biologist, newly released Boltz-2 targets binding affinity, and combating negativity besieging biotech

BioByte 119: e-tattoos that measure mental workload, introducing Biomni, FrankenROCS identifies drug candidates for Covid, and evolutionary watermarking to trace protein structures with FoldMark

BioByte 118: terraforming Mars, broadly neutralizing antibodies targeting HIV, bioprinting inside the body, and AI modeled on neurons for continuous thought

BioByte 117: biomanufacturing in space, predicting clinical trial outcomes, programmable bridge RNAs, and continuous evolution of CRISPR-associated transposases

BioByte 116: scaling test-time compute for antibody design, HealthBench sets the bar high for clinical LLMs, and revealing the structural secrets of human sweet receptors

BioByte 115: plant-permeable T6H increases wheat yields, AI in cognitive modeling, steps toward a universal snake antivenom, and advancements in conversational diagnostic AI

BioByte 114: reinforcement learning for LLMs, new 3D printing technique enables fully biologic tissue systems, Dual-Inf explains differential diagnoses, and a call for greater interpretability in AI

BioByte 113: solving the epigenome, psychopathological computations in LLMs, a novel protein circuit for mutated Ras, and desmosome mutations in skin cutaneous melanoma

BioByte 112: improvements in artificial wombs, motivational pathways of cachexia in cancer, introduction of AgentRxiv, and efficiency increases for de novo enzyme design

BioByte 111: nanoparticles for brain drug delivery, AI tackles spatial biology, a new structure prediction model for designing protein binders, and the colossal undertaking of recreating the dire wolf

BioByte 110: a blood test for diagnosing Alzheimer's, future behavior encoding in rats, entropy-reinforced planning in LLMs for drug discovery, & an exciting call to join Decoding Bio!